ISCA TECHNOLOGIES, INC. — Department of Defense SBIR Phase II: DHP13-004
ISCA TECHNOLOGIES, INC. — SBIR Phase II award from Department of Defense.
- Amount
- $1,500,000
- Agency
- Department of Defense · Defense Health Program
- Program / Phase
- SBIR · Phase II
- Topic
- DHP13-004
- Solicitation
- 13.2
- NAICS
- —
- Place of performance
- CA
- Period
- 2015-04-14 → 2018-10-14
Description
Protection of deployed ground forces from disease-carrying insects requires the immediate and safe use of insecticides. Currently, control products are too slow to manage target pests and are unrealistic solutions under battlefield conditions. Vector-borne diseases transmitted by insects, such as malaria, dengue and leishmaniasis, are increasing worldwide and are more of a threat to our military forces today than they were three decades ago. Disease transmitting insects are becoming resistant to an increasing number of public health insecticides with minimal research and development underway to search for replacements. The objective of Phase I research focused on the development of VECTRAX prototypes as attractive sugar bait formulations mixed with a toxicant that effectively kills target vectors without harming non-target animals. The results of this SBIR Phase I project have been remarkable, and VECTRAX is proving to be a viable solution for vector control. We will continue the development of optimal Attract and Kill (A&K) VECTRAX formulations targeted for disease spreading mosquitos, filth flies and sand flies. VECTRAX is designed to be a safe, effective and easily transportable product that will fill a significant gap in our ability to stop or prevent nuisance biting and disease transmission during military operations.